Edwards Lifesciences Net Long-Term Debt 2010-2025 | EW

Edwards Lifesciences annual/quarterly net long-term debt history and growth rate from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
  • Edwards Lifesciences net long-term debt for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Edwards Lifesciences net long-term debt for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Edwards Lifesciences annual net long-term debt for 2024 was $0B, a 0% decline from 2023.
  • Edwards Lifesciences annual net long-term debt for 2023 was $0B, a 0% decline from 2022.
  • Edwards Lifesciences annual net long-term debt for 2022 was $0B, a 100% decline from 2021.
Edwards Lifesciences Annual Net Long-Term Debt
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $-2
2020 $-1
2019 $-10
2018 $-437
2017 $176
2016 $222
2015 $2
2014 $-13
2013 $410
2012 $40
2011 $104
2010 $-48
2009 $-85
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $45.878B $5.440B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $191.291B 83.79
Thermo Fisher Scientific (TMO) United States $154.123B 18.64
Alcon (ALC) Switzerland $43.312B 29.27
IDEXX Laboratories (IDXX) United States $42.730B 49.10
DexCom (DXCM) United States $33.851B 52.32
IQVIA Holdings (IQV) United States $27.242B 15.26
Mettler-Toledo (MTD) United States $24.618B 29.28
STERIS (STE) Ireland $23.490B 25.87
Waters (WAT) United States $20.972B 29.59
SONOVA HOLDING (SONVY) Switzerland $17.819B 0.00
Hologic (HOLX) United States $14.487B 15.74
Sysmex ADR (SSMXY) Japan $10.827B 30.71
Penumbra (PEN) United States $9.930B 77.94
Masimo (MASI) United States $9.120B 33.64
Globus Medical (GMED) United States $7.933B 18.90
Glaukos (GKOS) United States $5.795B 0.00
Teleflex (TFX) United States $5.279B 8.71
TransMedics (TMDX) United States $4.446B 96.65
Integer Holdings (ITGR) United States $4.276B 22.41
PROCEPT BioRobotics (PRCT) United States $3.149B 0.00
LivaNova (LIVN) United Kingdom $2.495B 14.85
Veracyte (VCYT) United States $2.144B 30.09
Nihon Kohden (NHNKY) Japan $2.041B 23.41
Elekta AB (EKTAY) Sweden $1.933B 17.38
Alphatec Holdings (ATEC) United States $1.620B 0.00
Artivion (AORT) United States $1.332B 124.76
Tandem Diabetes Care (TNDM) United States $1.262B 0.00
OPKO Health (OPK) United States $1.047B 0.00
Pulse Biosciences (PLSE) United States $1.014B 0.00
Integra LifeSciences Holdings (IART) United States $0.955B 5.08
SiBone (SIBN) United States $0.785B 0.00
IRadimed (IRMD) United States $0.774B 39.25
Beta Bionics (BBNX) United States $0.653B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.565B 8.78
Mesa Laboratories (MLAB) United States $0.538B 12.62
OrthoPediatrics (KIDS) United States $0.519B 0.00
RxSight (RXST) United States $0.515B 0.00
AxoGen (AXGN) United States $0.478B 0.00
Delcath Systems (DCTH) United States $0.473B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.435B 0.00
Semler Scientific (SMLR) United States $0.429B 11.42
AngioDynamics (ANGO) United States $0.397B 0.00
Pacific Biosciences Of California (PACB) United States $0.387B 0.00
Treace Medical Concepts (TMCI) United States $0.362B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
ClearPoint Neuro (CLPT) United States $0.330B 0.00
Alpha Tau Medical (DRTS) Israel $0.253B 0.00
908 Devices (MASS) United States $0.241B 0.00
Tactile Systems Technology (TCMD) United States $0.240B 14.56
Neuronetics (STIM) United States $0.232B 0.00
Sight Sciences (SGHT) United States $0.222B 0.00
Biosig Technologies (BSGM) United States $0.209B 0.00
Inogen (INGN) United States $0.190B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
Rapid Micro Biosystems (RPID) United States $0.157B 0.00
CVRx (CVRX) United States $0.152B 0.00
LENSAR (LNSR) United States $0.150B 0.00
Anteris Technologies Global (AVR) Australia $0.146B 0.00
Accuray (ARAY) United States $0.142B 0.00
Lucid Diagnostics (LUCD) United States $0.127B 0.00
Atossa Genetics (ATOS) United States $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.080B 48.60
EnVVeno Medical (NVNO) United States $0.071B 0.00
InspireMD (NSPR) United States $0.070B 0.00
EDAP TMS S.A (EDAP) France $0.062B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Spectral AI (MDAI) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.038B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Baird Medical Investment Holdings (BDMD) $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.12
Spinal Elements Holdings (SPEL) United States $0.000B 0.00